| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.3M | +86.1% | — |
| Cost of Revenue | $137K | +49.7% | — |
| Gross Profit | $1.2M | +91.5% | — |
| R&D Expense | $846K | +588.3% | +318.4% |
| SG&A Expense | $1.8M | +166.7% | +229.2% |
| Operating Income | -$2.0M | -427.0% | -122.0% |
| Net Income | -$2.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $68K | -5.1% | +997.4% |
| Current Assets | $230K | +85.2% | +393.7% |
| Total Assets | $230K | +85.2% | +393.7% |
| Current Liabilities | $4.3M | +23.1% | +131.0% |
| Total Liabilities | $4.3M | +23.1% | +131.0% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.4M | — | — |
| Financing Cash Flow | $1.3M | — | — |
| -140.5% |
| EPS (Basic) | -$0.06 | -500.0% | -100.0% |
| EPS (Diluted) | -$0.06 | -500.0% | -100.0% |
| -$4.1M |
| -20.8% |
| -124.2% |